5-Methyl-2-pyridinesulfonamide

Catalog No.: 
ACQFZO596
CAS No.: 
65938-77-4
Molecular Formula: 
C6H8N2O2S
Molecular Weight: 
172.21
5-Methyl-2-pyridinesulfonamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
25g97%$154.00In stockIn stock
100g97%$490.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-Methyl-2-pyridinesulfonamide
IUPAC Name5-methylpyridine-2-sulfonamide
MDL No.MFCD00661363
Molecular FormulaC6H8N2O2S
Molecular Weight172.21
SMILESCC1=CN=C(C=C1)[S](=O)(=O)N
InChI KeyHXURYNQXMBRJLU-UHFFFAOYSA-N
Synonym5-Methyl-2-pyridinesulfonamide | A867567 | EN300-208228 | CS-W017596 | SB52434 | J-650264 | 5-methyl-2-pyridinesulphonamide | DTXSID70394266 | HXURYNQXMBRJLU-UHFFFAOYSA-N | FT-0686164 | MFCD00661363 | SY014673 | 5-Methyl-2-pyridinesulfonamide, >=97% | J-5
CAS No.65938-77-4
PubChem CID3614199

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACQFZO596 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACNWYG307 route compound structure diagram
    ACNWYG3073510-66-5In Stock
  2. Then
  3. ACQFZO596 route product structure diagram
    ACQFZO59665938-77-4In Stock
Inquiry

2. ACQFZO596 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACIHQT693 route compound structure diagram
    ACIHQT693179400-16-9In Stock
  2. Plus
  3. ACAYOL972 route compound structure diagram
    ACAYOL97210060-13-6In Stock
  4. Then
  5. ACQFZO596 route product structure diagram
    ACQFZO59665938-77-4In Stock
Inquiry

3. ACQFZO596 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACQFZO596 route product structure diagram
    ACQFZO59665938-77-4In Stock
Inquiry

Comments (0)